Safety and Efficacy of Beraprost Sodium Combined with Negative Pressure Drip Irrigation in the Treatment of Diabetic Foot Ulcer: A Retrospective Cohort Study

BackgroundDiabetic foot ulcer (DFU) is a major cause of infection-related hospitalization and amputation. Negative-pressure wound therapy with instillation and dwell time (NPWTi-d) is used for complex DFU, and beraprost sodium (BS), an oral prostacyclin analogue, may improve microcirculation; evidence for their combination is limited.ObjectiveTo assess the safety and effectiveness of NPWTi-d plus BS versus NPWTi-d alone and BS with standard wound care in DFU.MethodsWe retrospectively reviewed hospitalized DFU patients treated from February 2019 to April 2024. Of 667 screened patients, 590 met inclusion criteria and were grouped by therapy: NPWTi-d (<i>n</i> = 190), BS plus standard care (<i>n</i> = 200), and NPWTi-d plus BS (<i>n</i> = 200). Primary outcomes were 12-week healing rate, time to healing, and ulcer area reduction (ImageJ). Secondary outcomes included reinfection and DFU-related readmission at 12 weeks, 6 months, and 12 months, and quality of life (DFU-SF).ResultsAt 12 weeks, NPWTi-d plus BS achieved faster healing than NPWTi-d alone (mean difference 2.6 days; 95% CI 0.1-5.3; <i>P</i> = 0.042) and greater area reduction at weeks 8-12 (<i>P</i> < 0.05). DFU-SF improved in all groups, with consistently higher scores in the combination group (<i>P</i> < 0.001). Reinfection and readmission increased over time in all groups; between-group differences were small and may reflect residual confounding. No treatment-related serious adverse events were documented. No major bleeding, symptomatic hypotension, or treatment discontinuation due to intolerance was documented during the 12-week treatment period; minor adverse events may be underreported due to the retrospective design.ConclusionsIn this retrospective cohort, adding oral BS to NPWTi-d was associated with faster wound closure and better DFU-related quality of life. Prospective controlled studies are needed to confirm these findings.

Institutions

Publication Details

Journal
The International Journal of Lower Extremity Wounds
Published
2026-03-24
DOI
https://doi.org/10.1177/15347346261435112
Primary Topic
Diabetic Foot Ulcer Assessment and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Safety and Efficacy of Beraprost Sodium Combined with Negative Pressure Drip Irrigation in the Treatment of Diabetic Foot Ulcer: A Retrospective Cohort Study

The International Journal of Lower Extremity Wounds
Diabetic Foot Ulcer Assessment and Management
article

Safety and Efficacy of Beraprost Sodium Combined with Negative Pressure Drip Irrigation in the Treatment of Diabetic Foot Ulcer: A Retrospective Cohort Study

article en

Abstract

BackgroundDiabetic foot ulcer (DFU) is a major cause of infection-related hospitalization and amputation. Negative-pressure wound therapy with instillation and dwell time (NPWTi-d) is used for complex DFU, and beraprost sodium (BS), an oral prostacyclin analogue, may improve microcirculation; evidence for their combination is limited.ObjectiveTo assess the safety and effectiveness of NPWTi-d plus BS versus NPWTi-d alone and BS with standard wound care in DFU.MethodsWe retrospectively reviewed hospitalized DFU patients treated from February 2019 to April 2024. Of 667 screened patients, 590 met inclusion criteria and were grouped by therapy: NPWTi-d (<i>n</i> = 190), BS plus standard care (<i>n</i> = 200), and NPWTi-d plus BS (<i>n</i> = 200). Primary outcomes were 12-week healing rate, time to healing, and ulcer area reduction (ImageJ). Secondary outcomes included reinfection and DFU-related readmission at 12 weeks, 6 months, and 12 months, and quality of life (DFU-SF).ResultsAt 12 weeks, NPWTi-d plus BS achieved faster healing than NPWTi-d alone (mean difference 2.6 days; 95% CI 0.1-5.3; <i>P</i> = 0.042) and greater area reduction at weeks 8-12 (<i>P</i> < 0.05). DFU-SF improved in all groups, with consistently higher scores in the combination group (<i>P</i> < 0.001). Reinfection and readmission increased over time in all groups; between-group differences were small and may reflect residual confounding. No treatment-related serious adverse events were documented. No major bleeding, symptomatic hypotension, or treatment discontinuation due to intolerance was documented during the 12-week treatment period; minor adverse events may be underreported due to the retrospective design.ConclusionsIn this retrospective cohort, adding oral BS to NPWTi-d was associated with faster wound closure and better DFU-related quality of life. Prospective controlled studies are needed to confirm these findings.

The International Journal of Lower Extremity Wounds
Jiangnan University (CN), University Medical Center (US), Wuxi Fourth People's Hospital (CN)
Good health and well-being
Openalex Percentile: Top 13%
Diabetic Foot Ulcer Assessment and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.